Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference19 articles.
1. Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391(10127):1301–1314
2. Itoh S, Yugawa K, Shimokawa M et al (2019) Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection. BJS Open 3(4):500–508
3. Yoshizumi T, Ikegami T, Yoshiya S et al (2013) Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res 43(7):709–716
4. Takayasu K, Arii S, Sakamoto M et al (2018) Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤ 2 cm analysed with propensity score weighting. Liver Int 38(3):484–493
5. Llovet JM, Villanueva A, Marrero JA et al (2021) Trial design and endpoints in hepatocellular carcinoma: AASLD consensus conference. Hepatology 73(Suppl 1):158–191